Aspergillus fumigatus is a ubiquitous airborne fungus that can cause severe infections, especially in immunocompromised individuals, leading to life-threatening invasive diseases like invasive aspergillosis.
Hyperbaric oxygen therapy may inhibit Aspergillus fumigatus growth and enhance immune response, potentially improving treatment outcomes for patients with aspergillosis.